111 Inc (YI): Dodolan mangsa ngarep perusahaan

111, Inc. investments in cloud AI technologies for pharmaceuticals have driven a strategic shift prioritizing profitability over expansion. The company's planned sales volume clearly confirms this operational pivot, with the current figure standing at 1.50. Completing the picture is the creation of an integrated telemedicine and online delivery ecosystem, which radically simplifies access to quality healthcare for millions of Chinese citizens.

YI (111, Inc) riwayat Prakiraan volume dodolan saka 04.07.2022 nganti 14.11.2026

Rincian analitis perusahaan 111, Inc.

- rega saiki lan proyeksi nilai saham:

Kutipan saham 111, Inc.|YI - Target konsensus

- data kapitalisasi bursa:

Kapitalisasi pasar 111, Inc.|YI - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- indikator kapitalisasi buku:

Nilai Aset Bersih saben Saham 111, Inc.|YI - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku 111.com.cn|YI - Aset Agregat Perusahaan

- indikator beban kredit lan likuiditas emiten:

Utang Agregat marang Ekuitas 111, Inc.|YI - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal 111, Inc.|YI - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku 111, Inc|YI - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan 111, Inc.|Indikator likuiditas cepet 111.com.cn

- indikator pendapatan resik lan kelipatan nilai:

YI - Bathi resik|Proyeksi bathi mangsa ngarep 111, Inc.|YI - Pangali P/E|Prakiraan rega marang bathi 111, Inc.|YI - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan 111, Inc.|YI - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) 111, Inc.|YI - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan 111.com.cn|YI - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep 111, Inc.

- indikator volume dodolan lan pendapatan:

YI - Pendapatan reged perusahaan|Prakiraan pendapatan perusahaan 111, Inc.|YI - Rasio kapitalisasi marang pendapatan|Multiplikator Forward P/S 111, Inc

Analisis komprehensif perusahaan:111 Inc.

The integration of ESG principles into the digital pharmacy of 111, Inc. (YI) directly correlates with future sales volume dynamics. This metric measures the potential for scaling operations by analyzing the pace of market presence expansion. Assessing the organization's future sales allows for the verification of real capitalization growth on a daily timeframe. Logistics optimization and the digitalization of services create a foundation for a fundamental increase in revenue. The indicator's stable trend confirms the long-term sustainability of the business model.

Perusahaan pesaing

Volume dodolan mangsa ngarep perusahaan CVS (CVS Health Corporation)|Volume dodolan mangsa ngarep perusahaan mckesson.com MCK|Dodolan mangsa ngarep perusahaan COR|CAH - Volume dodolan mangsa ngarep perusahaan|HSIC (Henry Schein Corp) - Volume dodolan sing dikarepake perusahaan|PBH - Prakiraan volume dodolan|wellgisticshealth.com - Dodolan mangsa ngarep perusahaan|RDGT (jiuzhou360.com) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan Universe Pharmaceuticals INC UPC|Prakiraan volume dodolan Biodexa Pharma|Hong Kong Pharma Digital (HKPD) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan BIMI Holdings Inc (BIMI)|Prakiraan volume dodolan CJJD (China Jo-Jo Drugstores, Inc.)|Walgreens Boots Alliance Inc. - Prakiraan pendapatan perusahaan